Literature DB >> 10326718

Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia.

E Kilic1, Y G Ozdemir, H Bolay, H Keleştimur, T Dalkara.   

Abstract

Large infarcts develop in pinealectomized rats subjected to middle cerebral artery occlusion, which was attributed to loss of antioxidant action of melatonin. However, melatonin also has vascular actions, and pinealectomy may induce hypertension. The authors investigated (1) whether hemodynamic factors contribute to infarct development in pinealectomized rats, (2) whether melatonin administration can reverse the unfavorable effect of pinealectomy on infarct formation, and (3) whether melatonin can reduce the infarct volume in nonpinealectomized rats subjected to focal transient ischemia (2 hours middle cerebral artery occlusion, 22 hours reperfusion). Rats were pinealectomized 3 months before ischemia to eliminate any possible action of pinealectomy-induced hypertension on stroke. Blood pressure and regional CBF values during ischemia and reperfusion were not significantly different between pinealectomized and sham-operated rats, suggesting that pinealectomy-induced increase in infarct was not related to hemodynamic factors. The infarct volume resumed to the level of sham-operated rats on melatonin administration. Injection of melatonin (4 mg/kg) before both ischemia and reperfusion reduced infarct volume by 40% and significantly improved neurologic deficit scores in pinealectomized as well as sham-operated rats subjected to middle cerebral artery occlusion. These data suggest that physiologic melatonin release as well as exogenously given melatonin has a neuroprotective action in focal cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10326718     DOI: 10.1097/00004647-199905000-00005

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  35 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

Review 3.  Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing.

Authors:  Victoria E O'Collins; Malcolm R Macleod; Susan F Cox; Leena Van Raay; Elena Aleksoska; Geoffrey A Donnan; David W Howells
Journal:  J Cereb Blood Flow Metab       Date:  2010-10-27       Impact factor: 6.200

4.  Sleep deprivation aggravates median nerve injury-induced neuropathic pain and enhances microglial activation by suppressing melatonin secretion.

Authors:  Chun-Ta Huang; Rayleigh Ping-Ying Chiang; Chih-Li Chen; Yi-Ju Tsai
Journal:  Sleep       Date:  2014-09-01       Impact factor: 5.849

5.  Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release.

Authors:  Yalikun Suofu; Wei Li; Frédéric G Jean-Alphonse; Jiaoying Jia; Nicolas K Khattar; Jiatong Li; Sergei V Baranov; Daniela Leronni; Amanda C Mihalik; Yanqing He; Erika Cecon; Vanessa L Wehbi; JinHo Kim; Brianna E Heath; Oxana V Baranova; Xiaomin Wang; Matthew J Gable; Eric S Kretz; Giulietta Di Benedetto; Timothy R Lezon; Lisa M Ferrando; Timothy M Larkin; Mara Sullivan; Svitlana Yablonska; Jingjing Wang; M Beth Minnigh; Gérald Guillaumet; Franck Suzenet; R Mark Richardson; Samuel M Poloyac; Donna B Stolz; Ralf Jockers; Paula A Witt-Enderby; Diane L Carlisle; Jean-Pierre Vilardaga; Robert M Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

Review 6.  Physiological ischemia/reperfusion phenomena and their relation to endogenous melatonin production: a hypothesis.

Authors:  Dun-Xian Tan; Lucien C Manchester; Rosa M Sainz; Juan C Mayo; Josefa León; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 7.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

8.  Time-of-day determines neuronal damage and mortality after cardiac arrest.

Authors:  Zachary M Weil; Kate Karelina; Alan J Su; Jacqueline M Barker; Greg J Norman; Ning Zhang; A Courtney Devries; Randy J Nelson
Journal:  Neurobiol Dis       Date:  2009-08-05       Impact factor: 5.996

9.  Melatonin treatment decreases c-fos expression in a headache model induced by capsaicin.

Authors:  Fabiano C Tanuri; Eliângela de Lima; Mario F P Peres; Francisco R Cabral; Maria da Graça Naffah-Mazzacoratti; Esper Abrão Cavalheiro; José Cipolla-Neto; Eliova Zukerman; Débora Amado
Journal:  J Headache Pain       Date:  2009-01-27       Impact factor: 7.277

Review 10.  Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.

Authors:  Mahshid Yeganeh Salehpour; Adriano Mollica; Saeideh Momtaz; Nima Sanadgol; Mohammad Hosein Farzaei
Journal:  Clin Drug Investig       Date:  2019-07       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.